Coherus BioSciences
CHRS
$2.06
Share price
0.98%
Change (1 day)
-71.51%
Change (1 year)
Categories
Coherus BioSciences (CHRS) - Total debt
Total debt on the balance sheet as of December 2023 : $0.48 B
According to Coherus BioSciences 's latest financial reports the company's total debt is $0.48 B. A company’s total debt is the sum of all current and non-current debts.
Coherus BioSciences - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.48 B | 14.65% |
| 2021-12-31 | $0.41 B | 0.46% |
| 2020-12-31 | $0.41 B | 121.11% |
| 2019-12-31 | $0.18 B | 82.98% |
| 2018-12-31 | $0.10 B | 1.46% |
| 2017-12-31 | $0.10 B | 1.35% |
| 2016-12-31 | $0.10 B | |
| 2014-12-31 | $N/A | -100% |
| 2013-12-31 | $4.2 M | 141.83% |
| 2012-12-31 | $1.73 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $64.61 B | 13,337.47% | 🇺🇸 USA |
 Repligen
RGEN | $0.71 B | 48.03% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.19 B | -60.30% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |